International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.10002951
Original Article
Ultrasound Guided Hydrostatic Reduction of Intussusception in children
 ,
 ,
 ,
 ,
Published
Oct. 14, 2023
Abstract

Background: Intussusception is a common cause of intestinal obstruction in children, which requires prompt diagnosis and treatment in order to prevent, loss of bowel segment due to necrosis. Non operative management of intussusception is the treatment of choice. The aim of the study was to evaluate the efficiency of ultrasound guided hydrostatic reduction in treating intussusception.

Objective: The purpose of this study was to evaluate the clinical picture of cases undergoing USG guided hydrostatic reduction and to assess its outcome.

Materials and Methods: We conducted a retrospective study of intussusception cases who underwent USG guided hydrostatic reduction in our department of paediatric surgery, Tirunelveli medical college during the period of September 2021 to August 2023. A total 88 cases were included in the study.

Results: Mean age of the study participants was found to be 15.3±10.5 months with notable male predominance. Most common symptoms reported in this study was abdominal pain (76.1%) followed by vomiting (65.9%), abdominal distension (44.3%), blood in stools (35.2%), constipation (43.2%) and diarrhea (34.1%). All the cases underwent USG hydrostatic reduction however the success rate was reported as 85.2% and the rest of the cases underwent open manual reduction or resection anastomosis. Mean duration of stay in hospital was reported as 5.3±2.6 days and notably there were no mortality reported.

Conclusion: Ultrasound guided hydrostatic reduction is effective treatment modality option for intussusception, with high success rate & less morbidity.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
822 Views
243 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved